← All trials
NCT04815967
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 30, 2021
- Primary completion
- Jul 1, 2023
- Completion date
- Jul 1, 2024
- First posted
- Mar 25, 2021
- Last posted
- Jul 15, 2021
- Enrollment
- 272
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Supernus PharmaceuticalsLead sponsor
- Supernus PharmaceuticalsStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.